Livongo's flurry of recent activity is representative of a maturing digital therapeutics market — and its recent tie-ups reveal an approach digital therapeutics firms can take to wrangle in business.
And we've seen other players in the sector zeroing in on selling to insurers as a surefire way to capture a larger chunk of the market and rake in more cash: Diabetes management company DarioHealth that honing its budget in on its enterprise-facing channel — over its direct-to-consumer model — will drive revenue growth.$9 billion
by 2025, and we think that growth will largely be driven by increased payer appetite for products that improve health outcomes and reduce costs. So, it's likely that companies in the space will continue to focus more heavily on big-scale payer partnerships like this., Business Insider Intelligence's expert product suite keeping you up-to-date on the people, technologies, trends, and companies shaping the future of healthcare, delivered to your inbox 6x a week.
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessInsider - 🏆 729. / 51 Read more »